Home > Insider Trading > Filing (0001140361-17-045129)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636282	Aeglea Biotherapeutics Inc.	AGLE	Pharmaceutical Preparations (2834)	464312787

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1655962	Ii N Charles York	C/O Aeglea Biotherapeutics, Inc. 901 S. Mopac Expressway, Suite 250 Austin TX 78746	Chief Financial Officer And Vp	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-08-15	2,000	$3.99	10,828	No	5	P	Direct
Common Stock	Acquisiton	2017-02-15	2,000	$4.28	12,828	No	5	P	Direct
Common Stock	Acquisiton	2017-08-15	1,959	$2.52	14,787	No	5	P	Direct
Common Stock	Acquisiton	2017-12-01	6,500	$4.59	21,287	No	4	P	Direct
Common Stock	Acquisiton	2017-12-04	3,259	$4.97	24,546	No	4	P	Direct
Common Stock	Acquisiton	2017-12-05	10,241	$4.76	34,787	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $4.48 to $4.65 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $4.84 to $5.05 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $4.69 to $5.05 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.